REFRACTORY RHEUMATOID ARTHRITIS (RA)

Clinical trials for REFRACTORY RHEUMATOID ARTHRITIS (RA) explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY RHEUMATOID ARTHRITIS (RA) trials appear

Sign up with your email to follow new studies for REFRACTORY RHEUMATOID ARTHRITIS (RA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Off-the-Shelf immune cell therapy tested for multiple autoimmune diseases

Disease control Recruiting now

This study is testing whether adding a new type of immune cell therapy (called AlloNK) to an existing drug (rituximab) can better control several autoimmune diseases that have come back after standard treatments. The trial will enroll 90 adults with rheumatoid arthritis, Sjögren'…

Matched conditions: REFRACTORY RHEUMATOID ARTHRITIS (RA)

Phase: PHASE2 • Sponsor: Artiva Biotherapeutics, Inc. • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

REFRACTORY RHEUMATOID ARTHRITIS (RA)

Get alerted when new REFRACTORY RHEUMATOID ARTHRITIS (RA) trials appear

Off-the-Shelf immune cell therapy tested for multiple autoimmune diseases